Project Number 1U01AG060965-01 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator AGADJANYAN, MICHAEL G Principal Investigator First Name MICHAEL G Principal Investigator Last Name AGADJANYAN Awardee Organization INSTITUTE FOR MOLECULAR MEDICINE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-174: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,116,260 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
